Skip to main content

Table 1 Clinical and laboratory characteristics in patients with and without coronary artery disease

From: Relationship between epicardial adipose tissue, coronary artery disease and adiponectin in a Mexican population

  CAD- (n = 34) CAD + (n = 119) p value
Age (years) 59.18 ± 12.25 61.76 ± 10.05 0.210
Male gender, n (%) 14 (41.1) 98 (82.3) <0.001
BMI (kg/m2) 30.74 ± 5.90 28.92 ± 3.87 0.198
Central obesity n (%) 33 (97.0%) 118 (99.1%) 0.791
WC (cm) 100.97 ± 11.81 103.47 ± 8.81 0.256
Waist-hip ratio 0.92 ± 0.08 0.98 ± 0.06 <0.001
Smoking, n (%) 6 (17.6) 64 (53.7) <0.001
Diabetes mellitus, n (%) 13 (38.2) 65 (54.6) 0.093
Hypertension, n (%) 26 (76.5) 85 (71.4) 0.564
Hyperlipidemia, n (%) 24 (70.5) 85 (71.4) 0.924
Metabolic syndrome n (%) 29 (85.2) 111 (93.2) 0.141
FPG (mg/dl) 104.0 (95.00-119.25) 119.5 (97.00-152.25) 0.076
Total cholesterol (mg/dl) 175.97 ± 41 164.94 ± 48.55 0.231
LDL-C (mg/dl) 103.85 ± 33.58 91.63 ± 37.33 0.088
HDL-C (mg/dl) 42.35 ± 11.35 35.81 ± 8.94 0.003
TG (mg/dl) 141 (106.5-203.5) 151 (105.0-245.0) 0.353
hsCRP (mg/dl) 1.08 ± 2.08 3.01 ± 5.65 0.002
Adiponectin (μg/ml) 11.66 ± 6.77 8.88 ± 4.64 0.039
Fibrinogen (mg/dl) 547.0 (469.0-660.0) 591.5 (480.5-744.0) 0.090
  1. Data are expressed as number and % of patients, mean ± SD or median (25th, 75th percentiles). CAD – Coronary artery disease; BMI – Body mass index; WC – Waist circumference; FPG – fasting plasma glucose; LDL-C – low-density lipoprotein cholesterol; HDL-C – high-density lipoprotein cholesterol; TG – triglycerides; hsCRP – high sensitivity C-reactive protein. Central obesity was defined as increased waist circumference.